Company: GVH
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004806
Chunk: 17

Company: Globavend Holdings Ltd
Filing Date: 2025-04-15
Form: DRS
Chunk 17
---
 and financing requirements we may have. In the future, funds may not be available to fund operations or for other use outside of Hong Kong, due to interventions in, or the imposition of restrictions and limitations on, our ability or our subsidiary by the PRC government to transfer cash. Any limitation on the ability of our subsidiary to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Ordinary Shares or cause them to be worthless” in our Annual Report, which is
incorporated by reference herein.

During
the years ended September 30, 2022, 2023 and 2024, Globavend Holdings, Globavend BVI and Globavend Warehouse have not distributed any
cash dividends or made any other cash distributions. During the year ended September 30, 2024, Globavend HK has not distributed any cash
dividends or made any other cash distributions. During the year ended September 30, 2023, Globavend HK declared cash dividends in the
amount of US$1,474,359 (equivalent to HK$11,500,000) to our Controlling Shareholder. During the year ended September 30, 2022, Globavend
HK declared dividends in the amount of US$1,597,909 (equivalent to HK$12,463,692) to our Controlling Shareholder, of which US$1,244,502
(equivalent to HK$9,707,117) has been distributed as cash dividends and the remaining amount was offset with the entire amount
due to our Controlling Shareholder.

We
do not have any current intentions to distribute further earnings. If we determine to pay dividends on any of our Ordinary Shares in
the future, as a holding company, we will be dependent on receipt of funds from our HK Subsidiaries by way of dividend payments.
See “Dividend Policy” for further details.

We are an “emerging growth company” and a “foreign private issuer” as defined under the federal securities laws and, as such, are subject to reduced public company reporting requirements. See “ Prospectus Summary — Implications of Being an Emerging Growth Company and a Foreign Private Issuer” for additional information.

Neither the U.S. Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the